Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |